LMK CLINICAL RESEARCH CONSULTING Trademark

Trademark Overview


On Friday, September 11, 2015, a trademark application was filed for LMK CLINICAL RESEARCH CONSULTING with the United States Patent and Trademark Office. The USPTO has given the LMK CLINICAL RESEARCH CONSULTING trademark a serial number of 86753766. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, April 25, 2023. This trademark is owned by LMK Clinical Research Consulting LLC. The LMK CLINICAL RESEARCH CONSULTING trademark is filed in the Advertising, Business and Retail Services category with the following description:

Business consulting and process assessment services in the nature of providing information management services in the field of document management in clinical research trials
lmk clinical research consulting

General Information


Serial Number86753766
Word MarkLMK CLINICAL RESEARCH CONSULTING
Filing DateFriday, September 11, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, April 25, 2023
Registration Number5067069
Registration DateTuesday, October 25, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 9, 2016

Trademark Statements


NOT AVAILABLE"CLINICAL RESEARCH CONSULTING"
Goods and ServicesBusiness consulting and process assessment services in the nature of providing information management services in the field of document management in clinical research trials

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, September 16, 2015
Primary Code035
First Use Anywhere DateMonday, May 20, 2013
First Use In Commerce DateMonday, May 20, 2013

Trademark Owner History


Party NameTRANSPERFECT TECHNOLOGIES LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressSAN JUAN, PR 00918

Party NameLMK Clinical Research Consulting LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressHuntersville, NC 28078

Party NameLMK Clinical Research Consulting LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHuntersville, NC 28078

Party NameLMK Clinical Research Consulting LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHuntersville, NC 28078

Trademark Events


Event DateEvent Description
Tuesday, September 15, 2015NEW APPLICATION ENTERED
Wednesday, September 16, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 28, 2015ASSIGNED TO EXAMINER
Monday, January 4, 2016NON-FINAL ACTION WRITTEN
Monday, January 4, 2016NON-FINAL ACTION E-MAILED
Monday, January 4, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 30, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 30, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 1, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 5, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 20, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 9, 2016PUBLISHED FOR OPPOSITION
Tuesday, August 9, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 25, 2016REGISTERED-PRINCIPAL REGISTER
Monday, October 25, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, September 7, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, October 17, 2022TEAS SECTION 8 & 15 RECEIVED
Tuesday, April 25, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, April 25, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, April 25, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, February 9, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 9, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 9, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, October 26, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, October 27, 2025TEAS SECTION 8 & 9 RECEIVED